CIK 0001833769
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Hyperfine, Inc.
Sign in to watch- Ticker
- HYPR
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 866-796-6767
- Business address
- 351 NEW WHITFIELD STREET, GUILFORD, CT, 06437
- Former names
- HealthCor Catalio Acquisition Corp.
- 4 Open-market buy President and CEO bought 5,000 shares at $0.95 ($4,750)
- 4/A Open-market buy President and CEO bought 12,425 shares at $0.85 ($10,561)
- 4/A Open-market buy President and CEO bought 2,575 shares at $0.83 ($2,137)
- 4 Grant or award President and CEO acquired 12,425 shares (grant or award)
- 4 Grant or award President and CEO acquired 2,575 shares (grant or award)
- 4 Open-market buy Director bought 229,215 shares at $0.82 ($187,956)
- 4 Open-market buy Director bought 47,007 shares at $0.72 ($33,845)
- 4 Open-market sale CMO and Chief Strategy Officer sold 1,039 shares at $84.00 ($87,276)
- 4 Open-market sale Gen Counsel & Corp Secretary sold 1,895 shares at $0.84 ($1,592)
- 4 Open-market sale Chief Financial Officer sold 2,227 shares at $0.84 ($1,871)
- 4 Open-market buy Director bought 31,139 shares at $0.92 ($28,648)
- 4 Open-market buy Director bought 34,488 shares at $0.89 ($30,694)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CMO and Chief Strategy Officer sold 1,035 shares at $1.45 ($1,501)
- 4 Open-market sale Chief Financial Officer sold 8,871 shares at $1.45 ($12,863)
Page 4 of 8 · 144 filings